Key facts
- This page summarizes Jeremy Steven Davis's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 23 Feb 2023, 20:45.
Jeremy Steven Davis - 21 Feb 2023 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)
- Reporting relationship
- SVP Chief Commercial Officer
- Issuer ticker
- LAB
- Reported as of
- 21 Feb 2023
- Net transaction value
- -$12,537
- SEC form
- 4
- Accepted by SEC
- 23 Feb 2023, 20:45:13 UTC
- Prior SEC filing
- 20 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeremy Davis
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jeremy Steven Davis filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 23 Feb 2023.
Change
- Previous filing in this sequence was filed on 20 Jan 2023.
- Current net transaction value: -$12,537.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LAB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +20,833
- Change %
- Price
- $0.000000
- Shares after
- 20,833
- Date
- 21 Feb 2023
- Ownership
- Direct
LAB
transaction
Common Stock
Tax liability
- Transaction value
- $12,537
- Shares
- -6,176
- Change %
- -30%
- Price
- $2.03
- Shares after
- 14,657
- Date
- 21 Feb 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LAB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -20,833
- Change %
- -8.3%
- Price
- $0.000000
- Shares after
- 229,167
- Date
- 21 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,833
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
Footnote F2
On December 20, 2022, the Reporting Person was granted 250,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023.